Development of HER-2/Neu (HER2) ICD memory immunity after vaccination with a plasmid encoding HER2 ICD in patients with advanced stage HER2 overexpressing breast and ovarian cancers.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cancer vaccine HER-2 neu (Primary)
- Indications Advanced breast cancer
- Focus Pharmacodynamics
- 05 Apr 2017 Biomarkers information updated
- 11 Oct 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Oct 2012 Planned end date changed from 1 May 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.